Stay updated on Cabozantinib for PN in NF1: Clinical Trial
Sign up to get notified when there's something new on the Cabozantinib for PN in NF1: Clinical Trial page.
Latest updates to the Cabozantinib for PN in NF1: Clinical Trial page
- Check2 days agoChange DetectedThe page shows a minor site template revision: an update from v3.4.0 to v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%
- Check9 days agoChange DetectedThe page now displays a glossary and includes updated metadata such as 'Last Update Submitted that Met QC Criteria', 'No FEAR Act Data', and Revision: v3.4.0. Older items such as 'Last Update Submitted that met QC Criteria', 'No FEAR Act data', and Revision: v3.3.4 were removed; To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%
- Check17 days agoNo Change Detected
- Check24 days agoChange DetectedRevision updated from v3.3.3 to v3.3.4; no visible changes to the study page.SummaryDifference0.0%
- Check45 days agoChange DetectedLocations section added listing all sites by state and state-specific location headers removed, consolidating site information in one place. Revision updated to v3.3.3.SummaryDifference1%
- Check73 days agoChange DetectedPubMed-related notes in the Publications and Deletions sections were updated, adding Revision: v3.3.2 for additions and Revision: v3.2.0 for deletions.SummaryDifference0.1%
- Check81 days agoChange DetectedA notice about a lapse in government funding and potential delays was removed from the page; core trial details such as eligibility, endpoints, and locations remain unchanged.SummaryDifference0.3%
Stay in the know with updates to Cabozantinib for PN in NF1: Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Cabozantinib for PN in NF1: Clinical Trial page.